Marion Odence-Ford

Insider Reports History

Entity
Individual
Location
400 Water Street, Suite 200, Rochester, MI
Signature
/s/ Marion K. Odence-Ford
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marion Odence-Ford:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OptimizeRx Corp General Counsel and CCO Common Stock 14.2K $227K $15.95 Mar 1, 2024 Direct
OptimizeRx Corp General Counsel and CCO Stock Option 11.8K $88.5K $7.51 Dec 19, 2023 Direct
OptimizeRx Corp General Counsel and CCO Restricted Stock Units 771 $11.9K $15.39 Mar 1, 2024 Direct

Insider Reports Filed by Marion Odence-Ford

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OPRX OptimizeRx Corp Mar 1, 2024 3 -$4.27K 4 Mar 6, 2024 General Counsel and CCO
OPRX OptimizeRx Corp Feb 15, 2024 1 $0 4 Apr 24, 2024 General Counsel and CCO
OPRX OptimizeRx Corp Feb 11, 2024 3 -$21.3K 4 Feb 13, 2024 General Counsel and CCO
OPRX OptimizeRx Corp Jan 9, 2024 1 -$60.8K 4 Jan 11, 2024 General Counsel and CCO
OPRX OptimizeRx Corp Dec 19, 2023 2 $0 4 Feb 21, 2024 General Counsel and CCO
OPRX OptimizeRx Corp Nov 8, 2023 3 -$4.83K 4 Nov 13, 2023 General Counsel and CCO
OPRX OptimizeRx Corp Oct 3, 2023 3 -$13.8K 4 Oct 6, 2023 General Counsel and CCO
OPRX OptimizeRx Corp Mar 1, 2023 3 -$4.85K 4 Mar 3, 2023 General Counsel and CCO
OPRX OptimizeRx Corp Feb 11, 2023 3 -$24.7K 4 Feb 14, 2023 General Counsel and CCO
OPRX OptimizeRx Corp Nov 8, 2022 3 -$10.3K 4 Nov 10, 2022 General Counsel and CCO
OPRX OptimizeRx Corp Oct 3, 2022 2 $0 4 Oct 5, 2022 General Counsel and CCO
OPRX OptimizeRx Corp Aug 26, 2022 1 $15.8K 4 Aug 30, 2022 General Counsel and CCO
OPRX OptimizeRx Corp Mar 1, 2022 2 $0 4 Mar 3, 2022 General Counsel and CCO
OPRX OptimizeRx Corp Feb 11, 2022 2 $0 4 Feb 15, 2022 General Counsel and CCO
OPRX OptimizeRx Corp Nov 8, 2021 2 $0 4 Nov 10, 2021 General Counsel and CCO